A guide, not a pitch

Caution notes for traders.

A guide to reading any Expert Advisor's evidence — including ours.

Every automated trading product comes with a chart, a headline number, and a reason to believe it. Most of those charts are real. Most of those numbers are calculated correctly. And most of them still don't tell you what you actually need to know before risking money on them. This page isn't about any specific product — it's the questions we'd want a careful trader to ask about anything they're considering, Axis 7even included. At the bottom, we tell you plainly where we stand on each one.

1

Ask what's actually been tested, and how

The question to askIs this a backtest, a live account, or both?

Here's the thing worth understanding: a backtest isn't a red flag by itself. Every EA has to start somewhere, and no one can wait five years to publish any evidence at all — that would be an absurd bar, and it would leave you with nothing to evaluate for years. Backtests are a normal, necessary part of the evidence. Some of the most rigorous evidence we can offer is backtest evidence, tested across multiple brokers and multiple years, and we say so directly.

What actually matters is whether the backtest itself is methodologically honest. Was it run on real tick data, or generated/interpolated data that fills gaps with guesses? Does it disclose its “history quality” percentage, and is that percentage high? Was it tested on more than one broker's data feed, or does it live or die on a single, unverifiable source? A backtest that's been stress-tested across independent brokers and years is a genuinely different thing from one run once, on one feed, with parameters that happen to fit that exact feed perfectly.

2

Check whether the win rate matches the payoff

The question to askWhen you compare the average winning trade to the average losing trade, does the ratio make sense next to the win rate?

A very high win rate — 85%, 90%, higher — sounds like exactly what you want. But a win rate on its own tells you nothing about risk. What tells you something is putting it next to the size of a typical win versus the size of a typical loss.

If the win rate is extremely high and the average loss is meaningfully larger than the average win, that's a specific, recognizable shape. It usually means a system is finding ways to close small, marginal trades in the “win” column — by holding a losing position longer, or by adding to it — rather than taking a clean, predefined loss and moving on. That approach can produce an impressive-looking win-rate streak for a long time. It's also, structurally, the same shape that produces the rare but severe drawdown when the market finally moves too far or too fast for the recovery mechanism to work. The high win rate isn't the risk. The size of the rare loss is.

This is genuinely checkable from any report a seller publishes. Look at “average profit trade” next to “average loss trade.” If the ratio looks upside down relative to the win rate, ask why, specifically — not rhetorically.

3

Treat extreme risk-adjusted numbers as a flag, not a selling point

The question to askDoes the Sharpe ratio, Profit Factor, or Recovery Factor look dramatically higher than everything else you're comparing it to?

These numbers exist to describe how much return a strategy produced relative to how much risk it took on the way there. They're useful precisely because genuine, sustainable systematic strategies tend to cluster in a fairly consistent range — and numbers that sit far outside that range, sustained for years, are unusual enough that experienced allocators treat them as something to investigate, not something to celebrate. A Sharpe ratio in the double digits, held over a multi-year window, is the kind of figure that should prompt a closer look at how it was calculated and what data it's drawn from — not automatic excitement.

When a retail EA advertises numbers like that, there are really only a few honest explanations: the backtest window was chosen or shaped to fit unusually favorable conditions, the strategy is quietly taking on a form of risk that hasn't shown up yet in the sample, or the statistic is being calculated in a way that doesn't match how it's normally defined. None of those are disqualifying on their own — but “the number is dramatically higher than the rest of the field” is a real, specific thing to notice, not just an intuition to brush aside.

4

Read the exact wording on risk-mechanism claims

The question to askDoes the listing say a technique is absent, or does it say the technique isn't used by default?

Watch for phrasing like “does not use martingale in its recommended default configuration” or “does not rely on unlimited recovery cycles.” These are carefully constructed sentences. They can be entirely accurate and still leave real room for the underlying mechanism to exist in the code, available to be switched on, present in a non-default mode, or active in a way the plain-English summary doesn't quite rule out.

The more useful question isn't “does the marketing say no martingale” — it's “has anyone independently verified that, against the actual behavior, not just the product description.” If a seller can't point you to that kind of verification, that's worth knowing before you decide how much to trust the claim.

5

Look for independent verification, not just self-reported results

The question to askCan you check any of this yourself, or does it all originate from the seller?

A results table is easy to generate. A results table that's been tested by someone with no financial interest in the outcome — across more than one broker, ideally with the methodology published so it can be checked — is a genuinely different category of evidence. If a product's entire case rests on charts and numbers that only the seller has ever produced, that's not automatically dishonest, but it does mean you're the one taking their word for it.

6

Notice how the marketing itself is trying to make you feel

The question to askIs this page informing you, or is it trying to create urgency before you've had time to think?

Scarcity counters, countdown-style pricing, and results presented in bold celebratory colors are marketing techniques, not evidence. None of them are inherently dishonest — a genuinely limited launch allocation is a real thing, and we use one ourselves. But it's worth noticing when a page is working harder to make you feel like you're about to miss out than it is working to show you something you could verify. The two aren't mutually exclusive, but when a listing leans heavily on the first and lightly on the second, that's information too.

Where Axis 7even stands

We're not writing this page from the outside. Here's exactly where we are, measured against our own questions, as of publication.

Backtest and live status, stated plainly

Axis 7even has been trading live for 2 months and is currently profitable. Two months is not enough time to draw statistical conclusions from, and we say that plainly rather than implying otherwise.

What we do have is extensive backtest evidence: standardized annual tests for 2023, 2024, 2025 and 2026 to date, each restarting from €10,000 so no year borrows an edge from the last, plus continuous compounding tests that show what those same years produce left uninterrupted. Every figure is labeled with its actual window and test type — annual or continuous, backtest or live — never blurred together. Once we have a meaningful live sample, expected end of January 2027, we'll publish the full live results alongside the backtest evidence, not instead of it.

Win rate versus payoff

This is directly checkable, so here it is: across the three editions, the average winning trade is roughly 1.9–2.1× the average losing trade — around €5,980 average win against a €2,930 average loss. That's a win rate with wins meaningfully larger than losses — the direct inverse of the shape described above, where an extreme win rate is paired with losses that dwarf the wins. Full trade breakdowns for every tested window are in the Historical Testing & Validation Report.

Risk-adjusted numbers

Sharpe ratios run 4.05–4.58 across the three editions. Profit Factor runs 1.67–1.80. Recovery Factor runs 6.04–7.48. These sit in the same range as the strongest, most established systematic strategies on the market — strong numbers, not extreme ones. Some EAs advertise Sharpe ratios or Recovery Factors in the double digits; numbers that far outside the normal range are exactly what should prompt a closer look at how they were calculated, not automatic confidence.

Martingale and grid claims

We don't say “not in the default configuration.” The system structurally cannot open a second position on a symbol while one is open — verified directly against the source code, not asserted in marketing copy. That alone rules out grid trading and simultaneous position-stacking entirely.

Sequential martingale — closing a loss, then opening the next trade bigger specifically because of it — is a separate question, and we want to be precise about it: position sizing scales down, never up, after recent underperformance, at three independent levels — per-engine health, portfolio-wide drawdown throttle, and account-level guard. That's the opposite of a martingale recovery mechanism by design. We've directly verified the position-blocking rule against the code; the sizing-scales-down behavior is consistent throughout the documented architecture and the win/loss figures above.

Independent verification

Every figure is tested across four separate, independent brokers — BlackBull, Pepperstone, IC Markets and FxPro — not just the one we publish as the reference. MT4 and MT5 implementations have completed cross-platform decision parity testing (360/360 matched trade decisions for Focused, 468/468 for Core, with €0.00 reconstructed difference). For Specialist's Nasdaq module specifically, cross-broker portability was tested against independent NQ futures market data, not just another broker's feed: 23 exact matched entries between two brokers, 88.5% median zone overlap, and a 0.9996 correlation against that outside reference. None of this is self-reported without a way to check it — the full methodology is downloadable.

Marketing pressure versus disclosure

We do use a limited launch allocation — the first 50 licenses for Focused and Core, 30 for Specialist — and we tell you exactly what happens next: once that allocation sells, pricing is reviewed against the live evidence that's accumulated by then, not against a countdown clock. If live performance continues to support the historical profile, the next allocation is priced higher. If it doesn't, that's information too. Every claim on our site links back to the underlying report rather than standing alone as a headline number.

If you take one thing from this page, take this: ask these same six questions about us. We'd rather you check than trust us by default.

Axis 7even

Check the evidence yourself.

Download the full methodology, compare brokers, and read the numbers this page is asking you to question — including ours.